Safety of Treatment of Shoulder Repair

NCT ID: NCT04552119

Last Updated: 2025-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-30

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter, prospective, post-marketing, observational, case series study to evaluate the safety and efficacy of the HEALICOIL Knotless Suture Anchors in subjects with rotator cuff tendon repair. Approximately 160 subjects will be enrolled at up to 6 sites. Safety monitoring will include documentation device- and surgery-related AEs. Efficacy will be monitored by assessment of post-operative follow up, clinical complications, reoperation rate, EQ-5D-5L, and pain VAS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HEALICOIL Knotless Suture REGENESORB

HEALICOIL™ Knotless Suture Anchor in Shoulder Rotator Cuff Tendon Repair using HEALICOIL Knotless REGENESORB

HEALICOIL Knotless REGENESORB

Intervention Type DEVICE

HEALICOIL Knotless REGENESORB Self -Tapping HEALICOIL Knotless REGENSORB Non-Self Tapping

HEALICOIL Knotless PEEK

HEALICOIL™ Knotless Suture Anchor in Shoulder Rotator Cuff Tendon Repair using HEALICOIL Knotless PEEK

HEALICOIL Knotless PEEK

Intervention Type DEVICE

HEALICOIL Knotless PEEK Self-Tapping HEALICOIL Knotless Non-Self Tapping

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HEALICOIL Knotless PEEK

HEALICOIL Knotless PEEK Self-Tapping HEALICOIL Knotless Non-Self Tapping

Intervention Type DEVICE

HEALICOIL Knotless REGENESORB

HEALICOIL Knotless REGENESORB Self -Tapping HEALICOIL Knotless REGENSORB Non-Self Tapping

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Requires reattachment of soft tissue to bone for the following shoulder indications:

1. Rotator Cuff Tendon repair

* i. Single or double row rotator cuff repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping; OR
* ii. Double row rotator cuff repair using HEALICOIL Knotless RG NST in lateral row (existing HEALICOIL RG device to be used in medial row of the repair); AND/OR
2. Biceps tenodesis

* i. In conjunction with Rotator Cuff Tendon repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, HEALICOIL Knotless RG NST or HEALICOIL Knotless RG Self-Tapping OR
* ii. As a stand-alone procedure for HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping (not HEALICOIL Knotless RG NST
2. Has a pre-operative standard of care MRI within 6 months of surgery containing the following sequences:

1. Sat T2 FS: Oblique Sag T2-weighted Fat Saturation Spin Echo (oriented perpendicular to the scapula), with TE \> 70 ms, AND
2. Cor T2 FS: Oblique Cor T2-weighted Fat Saturation Spin Echo (oriented parallel to the scapula), with TE \> 70 ms, AND
3. Sag T1: Oblique Sag T1-weighted Spin Echo (oriented perpendicular to the scapula); OR
4. Willing and able to undergo an additional study specific pre-operative MRI according to the study Imaging Protocol if the above criteria is not met OR
5. MRI not required; subject not in HEALICOIL RG NST subgroup
3. Has consented to participate in the study by signing the IRB/IEC approved informed consent form.
4. Requires only one variant of the HEALICOIL Knotless Suture Anchor
5. Is ≥18 years of age at time of surgery
6. Willing and able to make all required study visits
7. Able to follow instructions (Approved translated documents supplied upon request)

Exclusion Criteria

* Any one (1) of the following criteria will disqualify a potential subject from participation in the study:

1. Known hypersensitivity to the implant material. Where material sensitivity is suspected, appropriate tests should be made and sensitivity ruled out prior to implantation.
2. Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation.
3. Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture.
4. Comminuted bone surface, which would compromise secure anchor fixation.
5. Physical conditions which would eliminate, or tend to eliminate, adequate anchor support or retard healing
6. The presence of infection.
7. Conditions which would limit the subject's ability or willingness to restrict activities or follow directions during the healing period.
8. Concurrent bilateral surgery.
9. Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1, or during the study.
10. Women who are pregnant.
11. Prior ipsilateral surgeries performed on the joint space.
12. Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Smith & Nephew, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karlie Morgan

Role: STUDY_CHAIR

Smith & Nephew, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Stanford

Redwood City, California, United States

Site Status

Orthopaedic and Spine Center of Southern Colorado

Colorado Springs, Colorado, United States

Site Status

University of Colorado - Denver

Denver, Colorado, United States

Site Status

OrthoIllinois LTD

Rockford, Illinois, United States

Site Status

University Orthopedics Center

Altoona, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HEALICOIL.KNOTLESS.2019.12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.